SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo
Dengue is endemic in more than 120 countries, with Asia contributing to 70% of the global burden (1). Dengue virus (DENV) circulates in four serotypes (DENV 1–4), each containing multiple distinct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results